— Know what they know.
Not Investment Advice
Also trades as: EVT.DE (XETRA) · $vol 3M · EVT.SW (SIX) · $vol 1M · 0IRF.IL (IOB) · $vol 0M · EVO (NASDAQ) · $vol 0M

EVOTF OTC

Evotec SE
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +7.7% 1Y: -8.1% 3Y: -59.9% 5Y: -83.2%
$6.69
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 56 · $1.2B mcap · 148M float · 0.0000% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$797M +2.0% ▲
5Y CAGR: +12.3%
Gross Profit
$115M -34.4% ▼
5Y CAGR: -2.9%
Operating Income
-$143M -200.0% ▼
Net Income
-$196M -133.7% ▼
EPS (Diluted)
$-1.11 -136.2% ▼
EBITDA
-$81M -434.3% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$501M$618M$751M$781M$797M
YoY Growth+12.2%+23.4%+21.6%+4.0%+2.0%
Cost of Revenue$375M$466M$577M$606M$682M
Gross Profit$126M$152M$174M$175M$115M
Gross Margin25.1%24.5%23.2%22.4%14.4%
R&D Expenses$64M$72M$77M$74M$51M
SG&A Expenses$77M$105M$156M$170M$188M
Operating Expenses$74M$110M$153M$223M$257M
Operating Income$49M$41M$21M-$48M-$143M
Operating Margin9.7%6.6%2.8%-6.1%-17.9%
Interest Expense$8M$9M$13M$12M$12M
Income Before Tax$26M$237M-$154M-$81M-$194M
Tax Expense$20M$21M$22M$3M$2M
Net Income$6M$216M-$176M-$84M-$196M
Net Margin1.3%34.9%-23.4%-10.7%-24.6%
EPS (Diluted)$0.04$1.29$-0.99$-0.47$-1.11
EBITDA$90M$314M-$59M$24M-$81M
Shares Outstanding155M167M177M177M177M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms